An FDA expert said the two-year deal reached by Congress and the White House on Monday (July 22) to raise the government’s budget caps is good for FDA in that it moves Congress closer to passing a 6% funding increase for the agency for fiscal 2020. Even better news, he said, is that offsets negotiated to pay for raising the budget caps would not affect FDA. A spokesperson for Senate Appropriations Committee Chair Richard Shelby (R-AL) told Inside Health Policy...